Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

NCT05390710

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • The first affiliated hopsital of bengbu medical college Bengbu, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Sun Yat-sen Memorial Hospital Guangzhou, China
  • Sir RunRun Shaw Hospital Zhejiang University School of Medicine Hangzhou, China
View Trial Details
Completed

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers

NCT03251378

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • California Cancer Care Associates for Research & Excellence, Inc. San Marcos, California, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View Trial Details

Related conditions